SEC Form 4 · accession 0001104659-15-027095
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Diane G. Gerst
Officer — Corp. SVP of Quality Assurance
Period of report
Apr 9, 2015
Accepted (ET)
Apr 10, 2015 · 7:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 8, 2015 | M | 10,000 | $14.80 | A | 29,496 | D | |
| Common Stock | Apr 8, 2015 | S | 10,000 | $15.79 | D | 19,496 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $14.80 | Apr 9, 2015 | A | 10,000 | D | — | May 15, 2025 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2014.
- F2Shares subject to the option are fully vested and immediately exercisable.